<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>SeriesFusion | Clinical Medicine</title><description>Clinical Medicine papers published by SeriesFusion.</description><link>https://seriesfusion.com</link><item><title>A skin-mounted film turned pulse into color. In 13 people, an ordinary smartphone read the circuit-free signal with a per-beat waveform correlation of 0.94 against a clinical reference.</title><link>https://pubmed.ncbi.nlm.nih.gov/42559738/</link><guid isPermaLink="true">https://pubmed.ncbi.nlm.nih.gov/42559738/</guid><description>Circuit-Free Cardiovascular Monitoring via Smartphone-Readable Skin-Interfaced Nanophotonic Films | Biomedical Engineering. Original: 42559738</description><pubDate>Fri, 07 Aug 2026 12:00:00 GMT</pubDate><category>Biomedical Engineering</category><category>biomedical-engineering</category></item><item><title>Hydrogel particles stretched into aligned microscopic fibers. SHIFT printing formed 5 to 30 micrometre fibers inside flowing gel, supported exceptionally long muscle cells in culture, and accelerated repair after volumetric muscle loss.</title><link>https://pubmed.ncbi.nlm.nih.gov/42557327/</link><guid isPermaLink="true">https://pubmed.ncbi.nlm.nih.gov/42557327/</guid><description>In situ particle-to-fibre transformation of hydrogels for 3D printing | Biomedical Engineering. Original: 42557327</description><pubDate>Fri, 07 Aug 2026 12:00:00 GMT</pubDate><category>Biomedical Engineering</category><category>biomedical-engineering</category></item><item><title>Engineered vesicles edited a primate brain. A redesigned guide-RNA scaffold and scalable manufacturing raised potency 300-fold, then delivered CRISPR editing against MSH3, a driver of Huntington&apos;s disease progression.</title><link>https://www.biorxiv.org/content/10.64898/2026.08.05.741964</link><guid isPermaLink="true">https://www.biorxiv.org/content/10.64898/2026.08.05.741964</guid><description>Efficient genome editing in the non-human primate brain using programmable extracellular vesicles | Pharmacology. Original: 10.64898</description><pubDate>Fri, 07 Aug 2026 12:00:00 GMT</pubDate><category>Pharmacology</category><category>pharmacology</category></item><item><title>Sixty billion lab-grown platelets entered one patient. The single-subject trial reported no adverse events, a temporary platelet-count increase, and evidence that allogeneic iPSC-derived platelets circulated in the bloodstream.</title><link>https://pubmed.ncbi.nlm.nih.gov/42560886/</link><guid isPermaLink="true">https://pubmed.ncbi.nlm.nih.gov/42560886/</guid><description>First evidence of the circulation of induced pluripotent stem cell-derived platelets in humans | Pharmacology. Original: 42560886</description><pubDate>Fri, 07 Aug 2026 12:00:00 GMT</pubDate><category>Pharmacology</category><category>pharmacology</category></item><item><title>Dormant viruses reawakened during severe COVID-19. In 1,154 hospitalized patients, herpesviruses and anelloviruses tracked with inflammation, disease severity, clinical outcomes, and persistent reactivation during recovery without establishing causation.</title><link>https://pubmed.ncbi.nlm.nih.gov/42557313/</link><guid isPermaLink="true">https://pubmed.ncbi.nlm.nih.gov/42557313/</guid><description>Virus reactivation in acute and long COVID-19 | Trials. Original: 42557313</description><pubDate>Fri, 07 Aug 2026 12:00:00 GMT</pubDate><category>Trials</category><category>trials</category></item><item><title>Glutathione turns one drug into molecular glue. The activated M12 compound redirects the DCAF11 ligase toward DDX18, revealing a metabolically triggered route for destroying selected proteins.</title><link>https://pubmed.ncbi.nlm.nih.gov/42557329/</link><guid isPermaLink="true">https://pubmed.ncbi.nlm.nih.gov/42557329/</guid><description>DCAF11-dependent molecular glue degrader activated by glutathionylation | Pharmacology. Original: 42557329</description><pubDate>Fri, 07 Aug 2026 12:00:00 GMT</pubDate><category>Pharmacology</category><category>pharmacology</category></item><item><title>Fifteen lipid nanoparticles entered a stem-cell contest. The winning CD34-targeted carrier edited human blood-forming cells inside humanized mice, reactivated fetal haemoglobin, and partly restored neutrophil development in an ELANE model.</title><link>https://pubmed.ncbi.nlm.nih.gov/42557300/</link><guid isPermaLink="true">https://pubmed.ncbi.nlm.nih.gov/42557300/</guid><description>Engineered lipid nanoparticles for in vivo and durable editing of haematopoietic stem cells within humanized mice | Pharmacology. Original: 42557300</description><pubDate>Fri, 07 Aug 2026 12:00:00 GMT</pubDate><category>Pharmacology</category><category>pharmacology</category></item><item><title>One-day CAR T cells stayed stem-like longer. IL-18-armed cells avoided the usual activation step, resisted exhaustion, and maintained antitumor activity across mouse models of lymphoma, leukemia, and pancreatic cancer.</title><link>https://doi.org/10.1182/blood.2026033460</link><guid isPermaLink="true">https://doi.org/10.1182/blood.2026033460</guid><description>Single-day non-activated IL-18-armed CAR T-cells establish a durable, stem-like state with enhanced persistence | Pharmacology. Original: 10.1182/blood.2026033460</description><pubDate>Fri, 07 Aug 2026 12:00:00 GMT</pubDate><category>Pharmacology</category><category>pharmacology</category></item></channel></rss>